دورية أكاديمية
p38γ and p38δ Are Involved in T Lymphocyte Development.
العنوان: | p38γ and p38δ Are Involved in T Lymphocyte Development. |
---|---|
المؤلفون: | Risco A; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain., Martin-Serrano MA; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain., Barber DF; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain., Cuenda A; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain. |
المصدر: | Frontiers in immunology [Front Immunol] 2018 Jan 29; Vol. 9, pp. 65. Date of Electronic Publication: 2018 Jan 29 (Print Publication: 2018). |
نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
اللغة: | English |
بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
مواضيع طبية MeSH: | Cell Differentiation*, Mitogen-Activated Protein Kinase 12/*metabolism , Mitogen-Activated Protein Kinase 13/*metabolism , T-Lymphocytes/*cytology , T-Lymphocytes/*metabolism, Animals ; Biomarkers ; Gene Knockdown Techniques ; Lymphoid Tissue/metabolism ; Mice ; Mice, Knockout ; Mitogen-Activated Protein Kinase 12/genetics ; Mitogen-Activated Protein Kinase 13/genetics ; Receptors, Antigen, T-Cell, alpha-beta/metabolism ; Thymocytes/cytology ; Thymocytes/metabolism |
مستخلص: | p38 mitogen-activated protein kinase (MAPK) signal transduction pathways are essential regulators of the immune response. Particularly, p38γ and p38δ regulate many immune cell functions such as cytokine production, migration, or T cell activation; however, their involvement in immune cell development is largely unknown. Here, we analysed the role of p38 MAPK isoforms p38γ and p38δ in T cell differentiation in the thymus and in lymph nodes, using mice deficient in p38γ, p38δ, or in both. We found that the T cell differentiation program in the thymus was affected at different stages in p38γ-, p38δ-, and p38γ/δ-deficient mice, and also peripheral T cell homaeostasis was compromised. Particularly, p38δ deletion affects different stages of early CD4 - CD8 - double-negative thymocyte development, whereas lack of p38γ favours thymocyte positive selection from CD4 + CD8 + double-positive to CD4 + or CD8 + single-positive cells. Our results identify unreported functions for p38γ and p38δ in T cells. |
References: | EMBO J. 1995 Jan 16;14(2):276-85. (PMID: 7835338) Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1549-54. (PMID: 21205892) Arthritis Rheumatol. 2014 May;66(5):1208-17. (PMID: 24782184) Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):147-52. (PMID: 14694199) Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9089-94. (PMID: 22615377) Annu Rev Immunol. 1995;13:93-126. (PMID: 7612239) Nature. 2000 May 4;405(6782):91-4. (PMID: 10811224) J Exp Med. 2000 Jan 17;191(2):321-34. (PMID: 10637276) Mol Cell. 2000 Jul;6(1):109-16. (PMID: 10949032) Science. 1999 Nov 12;286(5443):1374-7. (PMID: 10558995) Nat Rev Immunol. 2002 May;2(5):309-22. (PMID: 12033737) Physiol Rev. 2012 Apr;92(2):689-737. (PMID: 22535895) Nat Rev Immunol. 2014 Aug;14(8):529-45. (PMID: 25060579) J Cell Sci. 2010 Aug 1;123(Pt 15):2596-604. (PMID: 20605917) Eur J Immunol. 2001 Oct;31(10):3056-63. (PMID: 11592082) Cancer Res. 2014 Nov 1;74(21):6150-60. (PMID: 25217523) EMBO J. 2005 Mar 23;24(6):1134-45. (PMID: 15729360) Nat Immunol. 2006 Nov;7(11):1143-9. (PMID: 17053799) Immunol Cell Biol. 2000 Apr;78(2):166-75. (PMID: 10762418) J Exp Med. 2012 Nov 19;209(12 ):2229-46. (PMID: 23129748) Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11200-5. (PMID: 22733747) Cell Signal. 2010 Apr;22(4):660-7. (PMID: 20004242) Immunity. 2006 Jan;24(1):53-64. (PMID: 16413923) J Exp Med. 2001 Sep 3;194(5):695-703. (PMID: 11535637) Biochem Soc Trans. 1997 Nov;25(4):S569. (PMID: 9449997) J Immunol. 1999 Apr 1;162(7):4246-52. (PMID: 10201954) Immunol Rev. 2003 Apr;192:131-42. (PMID: 12670401) Blood. 2000 Feb 15;95(4):1356-61. (PMID: 10666211) Trends Biochem Sci. 2017 Jun;42(6):431-442. (PMID: 28473179) Front Cell Dev Biol. 2016 Apr 14;4:31. (PMID: 27148533) Immunol Rev. 2009 Mar;228(1):212-24. (PMID: 19290930) Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10454-9. (PMID: 10973481) J Immunol. 2005 Feb 1;174(3):1239-44. (PMID: 15661878) Mol Cell Biol. 2005 Dec;25(23):10454-64. (PMID: 16287858) Oncotarget. 2015 May 30;6(15):12920-35. (PMID: 26079427) Curr Opin Immunol. 2010 Apr;22(2):185-92. (PMID: 20074925) J Biol Chem. 2012 Sep 28;287(40):33215-26. (PMID: 22859305) J Biol Chem. 2017 Feb 3;292(5):1762-1772. (PMID: 28011639) EMBO J. 1997 Jun 16;16(12 ):3563-71. (PMID: 9218798) Nature. 1995 Feb 16;373(6515):620-3. (PMID: 7854419) Oncogene. 2001 Apr 30;20(19):2490-7. (PMID: 11402343) Immunity. 1998 Oct;9(4):565-74. (PMID: 9806642) Blood. 2003 Feb 1;101(3):970-6. (PMID: 12393706) Cell. 2000 Jul 21;102(2):221-31. (PMID: 10943842) |
فهرسة مساهمة: | Keywords: lymph node; p38 mitogen-activated protein kinase; p38γ; p38δ; thymocyte development; thymus |
المشرفين على المادة: | 0 (Biomarkers) 0 (Receptors, Antigen, T-Cell, alpha-beta) EC 2.7.1.- (Mitogen-Activated Protein Kinase 12) EC 2.7.1.- (Mitogen-Activated Protein Kinase 13) |
تواريخ الأحداث: | Date Created: 20180214 Date Completed: 20190225 Latest Revision: 20190225 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC5796910 |
DOI: | 10.3389/fimmu.2018.00065 |
PMID: | 29434594 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1664-3224 |
---|---|
DOI: | 10.3389/fimmu.2018.00065 |